Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate-Reference-Cited by-同舟云学术

Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate

Published:2021-02-23 Issue:4 Volume:18 Page:1544-1557
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Brandis Joel E. P.¹^ORCID,Kihn Kyle C.¹,Taraban Marc B.¹^ORCID,Schnorr Julia²,Confer Alex M.³^ORCID,Batelu Sharon⁴,Sun Dajun⁵,Rodriguez Jason D.⁶,Jiang Wenlei⁵,Goldberg David P.³^ORCID,Langguth Peter²,Stemmler Timothy L.⁴^ORCID,Yu Yihua Bruce¹,Kane Maureen A.¹^ORCID,Polli James E.¹^ORCID,Michel Sarah L. J.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States

2. Department of Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg University Mainz, Staudingerweg 5, 55128 Mainz, Germany

3. Department of Chemistry, The Johns Hopkins University, Baltimore, Maryland 21218, United States

4. Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48201, United States

5. Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, United States

6. Division of Pharmaceutical Analysis, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, MO 20903, United States

Funder

U.S. Food and Drug Administration

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00922

Reference52 articles.

1. Minimum information reporting in bio–nano experimental literature

2. Nanotechnology and Nanomedicine: Start small, think big

3. FDA Guidance for Industry Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology; FDA, Office of the Commissioner, 2014.

4. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissimilar ferric derisomaltose formulations – In vitro comparisons between an originator and its intended similars;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Control of the Iron State in Pharmaceuticals Used for Treatment and Prevention of Iron Deficiency Using Mössbauer Spectroscopy;Journal of Pharmaceutical Sciences;2024-06

3. An Analytical Method for Determination of Total Iron in Pharmaceuticalgrade Intravenous Iron Colloidal Complexes by Redox-Potentiometry;Pharmaceutical Nanotechnology;2023-10

4. Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structure;European Journal of Pharmaceutical Sciences;2023-09

5. Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes;Journal of Visualized Experiments;2023-07-07